137 related articles for article (PubMed ID: 5684610)
21. Allopurinol (xanthine oxidase inhibitor) in the treatment of resistant gout.
Bartels EC
JAMA; 1966 Nov; 198(7):708-12. PubMed ID: 5953324
[No Abstract] [Full Text] [Related]
22. Therapy of gout.
Gaines LM
Johns Hopkins Med J; 1967 Nov; 121(5):361-4. PubMed ID: 6075623
[No Abstract] [Full Text] [Related]
23. Management of gout.
Simkin PA
Ann Intern Med; 1979 May; 90(5):812-6. PubMed ID: 434690
[TBL] [Abstract][Full Text] [Related]
24. [Drug therapy in uratic arthritis. II. Prevention of new attacks].
Alvsaker JO
Tidsskr Nor Laegeforen; 1977 May; 97(15):791-2. PubMed ID: 867395
[No Abstract] [Full Text] [Related]
25. Management of gout.
Gordon GV; Schumacher HR
Am Fam Physician; 1979 Jan; 19(1):91-7. PubMed ID: 760433
[TBL] [Abstract][Full Text] [Related]
26. Etiology and treatment of gout--modern concepts.
Riccitelli ML
J Am Geriatr Soc; 1968 Jun; 16(6):719-28. PubMed ID: 5675393
[No Abstract] [Full Text] [Related]
27. [Clinical findings and therapy of gout with special reference to the metabolic effects of sulfinpyrazone (Anturan) and allopurinol (Zyloric)].
Günther R; Knapp E
Wien Klin Wochenschr; 1969 Nov; 81(45):817-20. PubMed ID: 5362152
[No Abstract] [Full Text] [Related]
28. Allopurinol in the treatment of gout.
Woodbury JF; Mehta DM; Morse WI
N S Med Bull; 1969 Aug; 48(4):103-7. PubMed ID: 5258764
[No Abstract] [Full Text] [Related]
29. The treatment of gout.
Kersley GD
Scott Med J; 1973; 18():Suppl 1:249-50. PubMed ID: 4773968
[No Abstract] [Full Text] [Related]
30. [Treatment of gout with the combination of xanthine oxidase inhibitors and uricosuric agents].
Delbarre F; Saporta L; de Géry A; Jabre E
Rev Rhum Mal Osteoartic; 1970; 37(6):443-50. PubMed ID: 5453852
[No Abstract] [Full Text] [Related]
31. [Antarthritics. 41].
Mayr E
Pharm Prax; 1969 Dec; 12():267-9. PubMed ID: 4909745
[No Abstract] [Full Text] [Related]
32. [Gout in advanced age].
Holländer E; Schwarczmann P
Munch Med Wochenschr; 1968 Mar; 110(11):649-53. PubMed ID: 5754904
[No Abstract] [Full Text] [Related]
33. Long-term treatment of gout with "allopurinol".
Michotte JL; Burtonboy G
Acta Rheumatol Scand; 1968; 14(1):71-8. PubMed ID: 5649436
[No Abstract] [Full Text] [Related]
34. Biochemical effectiveness of allopurinol and allopurinol-probenecid in previously benzbromarone-treated gout patients.
Reinders MK; van Roon EN; Houtman PM; Brouwers JR; Jansen TL
Clin Rheumatol; 2007 Sep; 26(9):1459-65. PubMed ID: 17308859
[TBL] [Abstract][Full Text] [Related]
35. [Allopurinol in the treatment of gout].
Sabah D
Rev Med Chil; 1970; 98(9):622-7. PubMed ID: 5509800
[No Abstract] [Full Text] [Related]
36. Treatment of gout with allopurinol and sulphinpyrazone in combination and with allopurinol alone.
Kuzell WC; Seebach LM; Glover RP; Jackman AE
Ann Rheum Dis; 1966 Nov; 25(6 Suppl):634-42. PubMed ID: 5335061
[No Abstract] [Full Text] [Related]
37. The treatment of gout.
Wallace SL
Arthritis Rheum; 1972; 15(3):317-23. PubMed ID: 5031616
[No Abstract] [Full Text] [Related]
38. [Gout: diagnosis and therapy].
Schlapbach P
Ther Umsch; 1985 Oct; 42(10):687-90. PubMed ID: 3909489
[No Abstract] [Full Text] [Related]
39. [Physiopathological bases for a rational therapy of gout].
Pallalardo A; Gancitano A
Minerva Med; 1978 Feb; 69(6):389-402. PubMed ID: 305012
[TBL] [Abstract][Full Text] [Related]
40. Drugs for gout.
Med Lett Drugs Ther; 1976 Jun; 18(12):49-51. PubMed ID: 934016
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
